Directorate Changes
Further to the announcement made on 4th March 2011 regarding the appointments of Ms Judy Lewent and Ms Stacey Cartwright as Non-Executive Directors with effect from 1 April 2011, the Company confirms that there are no further disclosures to be made in accordance with Listing Rule 9.6.13R.
The Company lists below details of their interests in the Ordinary shares of GlaxoSmithKline plc:
|
Number of Ordinary Shares |
Ms J Lewent |
- |
Ms S L Cartwright |
121 |
V A Whyte
Company Secretary
11 March 2011